GlaxoSmithKline(GSK)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE 100

Market Cap

£63,099m

Change Today

Price Up22.00p

Share Price

1,209.00p

Latest ShareCast News

Sunday tips focus: Tesco, GSK, JD Sports

Date: Sunday 05 Oct 2008

It could have been far worse – just look at Marks & Spencer and its 6.7 per cent quarterly sales decline, It’s true that like-for-like UK sales growth excluding petrol was, at 3.7 per cent, the worst for eight years, but Tesco has weathered the storm well so far and the figure actually represents an acceleration of the rate on the first quarter.

GlaxoSmithKline Regulatory News

Director/PDMR Shareholding 07-Oct-2008 16:45 RNS
Director/PDMR Shareholding 01-Oct-2008 17:23 RNS
Total Voting Rights 01-Oct-2008 14:14 RNS
Transaction in Own Shares 29-Sep-2008 17:22 RNS
Interest in shares in Addex Pharmaceuticals Ltd 25-Sep-2008 18:23 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,209.00p Price Up
Change Today +22.00p
52 Week High 1,385.00
52 Week Low 1,001.00
Volume 20,713,360
Shares Issued 5,219m
Market Cap £63,099m
Beta 0.47
RiskGrade 126

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
77.26% below the market average77.26% below the market average77.26% below the market average77.26% below the market average77.26% below the market average
12.50% above the sector average12.50% above the sector average12.50% above the sector average12.50% above the sector average12.50% above the sector average
Price Trend
67.04% above the market average67.04% above the market average67.04% above the market average67.04% above the market average67.04% above the market average
66.29% above the sector average66.29% above the sector average66.29% above the sector average66.29% above the sector average66.29% above the sector average
Income
3.63% above the market average3.63% above the market average3.63% above the market average3.63% above the market average3.63% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth
64.59% below the market average64.59% below the market average64.59% below the market average64.59% below the market average64.59% below the market average
77.46% below the sector average77.46% below the sector average77.46% below the sector average77.46% below the sector average77.46% below the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 13
Sell 7
Strong Sell 5
Total 29
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q2 Q1
Ex-Div 30-Jul-08 30-Apr-08
Paid 09-Oct-08 10-Jul-08
Amount 13.00p 13.00p

Trades for 07-Oct-2008

Time Volume / Share Price
17:07 1,100 @ 1,207.26p
14:40 209 @ 1,213.02p
16:56 4,552 @ 1,207.93p
16:49 19,000 @ 1,212.84p
16:44 50,000 @ 1,208.00p

GlaxoSmithKline Key Personnel

CEO Jean-Pierre Garnier
CFO Julian Heslop
Chair Moncef Slaoui

Digital Look have been voted
"Best Research and Informataion Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).